Thrive Capital Management (Pennsylvania)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,050
| Closed | -$33.5K | – | 178 |
|
|
2025
Q1 | $33.5K | Hold |
10,050
| – | – | 0.02% | 113 |
|
|
2024
Q4 | $74.4K | Hold |
10,050
| – | – | 0.03% | 95 |
|
|
2024
Q3 | $94.4K | Hold |
10,050
| – | – | 0.04% | 176 |
|
|
2024
Q2 | $80.6K | Buy |
10,050
+50
| +0.5% | +$401 | 0.04% | 177 |
|
|
2024
Q1 | $148K | Hold |
10,000
| – | – | 0.08% | 118 |
|
|
2023
Q4 | $81.3K | Hold |
10,000
| – | – | 0.04% | 154 |
|
|
2023
Q3 | $45.5K | Buy |
+10,000
| New | +$45.5K | 0.03% | 135 |
|